Cargando…
Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients
BACKGROUND: Reports of severe COVID-19 being associated with thrombosis, antiphospholipid antibodies (APLA), and antiphospholipid syndrome have yielded disparate conclusions. Studies comparing patients with COVID-19 with contemporaneous controls of similar severity are lacking. METHODS: 22 COVID-19(...
Autores principales: | Trahtemberg, Uriel, Rottapel, Robert, Dos Santos, Claudia C, Slutsky, Arthur S, Baker, Andrew, Fritzler, Marvin J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076626/ https://www.ncbi.nlm.nih.gov/pubmed/33903092 http://dx.doi.org/10.1136/annrheumdis-2021-220206 |
Ejemplares similares
-
COVID-19-associated autoimmunity as a feature of acute respiratory failure
por: Trahtemberg, Uriel, et al.
Publicado: (2021) -
Influence of anticardiolipin and anti‐β2 glycoprotein I antibody cutoff values on antiphospholipid syndrome classification
por: Vanoverschelde, Laura, et al.
Publicado: (2019) -
Advances in the Research on Anticardiolipin Antibody
por: Wang, Dan, et al.
Publicado: (2019) -
Anticardiolipin Positivity Is Highly Associated With Intrauterine Growth Restriction in Women With Antiphospholipid Syndrome
por: Xi, Fangfang, et al.
Publicado: (2020) -
Antiphospholipid antibodies in critically ill patients
por: Vassalo, Juliana, et al.
Publicado: (2014)